Saroja Pharma In
: SAROJA · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Saroja Pharma In's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Saroja Pharma Industries India Limited is primarily engaged in the trading of pharmaceutical active ingredients (API), pharmaceutical intermediates, chemicals, and solvents. The company serves both human and veterinary medicine sectors through its trading operations.
Business Model
The company operates as a trading entity, sourcing chemical and pharmaceutical products to supply to various industrial and medical end-users.
Growth Outlook
Growth is expected to be driven by the expanding demand for pharmaceutical intermediates and chemical solvents within the Indian healthcare and veterinary markets.
Key Risks
- Supply Chain Volatility. As a trading company, the firm is susceptible to fluctuations in the availability and pricing of chemical and pharmaceutical raw materials.
- Regulatory Compliance. The business must adhere to stringent pharmaceutical and chemical handling regulations, which may impact operational costs if standards change.
- Market Competition. The trading sector for chemicals and APIs is highly fragmented, leading to intense price competition and pressure on profit margins.
- Foreign Exchange Risk. Fluctuations in currency exchange rates may affect the cost of imported chemicals and the profitability of international trade transactions.
Start your research today
Unlock AI insights, financials, peers and live data on Saroja Pharma In and 5,000+ companies — free.
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Saroja Pharma InSAROJA | ₹16 Cr | — | — | — | 5.4% | — | — | -17.0% |
Kronox Lab Sciences LimitedKRONOX | ₹666 Cr | 23.05 | 16.30 | 6.1% | 38.7% | 27.7% | 35.9% | +11.2% |
Black Rose IndusBLACKROSE | ₹584 Cr | 26.01 | 16.40 | — | 11.0% | 13.9% | 18.9% | +19.1% |
Vipul OrganicsVIPULORG | ₹506 Cr | 63.11 | 30.62 | 7.7% | 10.4% | 8.9% | 13.4% | +29.6% |
Plastiblends India LimitedPLASTIBLEN | ₹493 Cr | 11.54 | 6.83 | 5.5% | 9.2% | 9.7% | 12.8% | +0.5% |
Aarti SurfactantAARTISURF | ₹458 Cr | 24.91 | 9.80 | 25.2% | 6.1% | 7.7% | 12.4% | +19.0% |
As of Mar 2026
Financials
Saroja Pharma In
: SAROJA · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Saroja Pharma In's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Saroja Pharma Industries India Limited is primarily engaged in the trading of pharmaceutical active ingredients (API), pharmaceutical intermediates, chemicals, and solvents. The company serves both human and veterinary medicine sectors through its trading operations.
Business Model
The company operates as a trading entity, sourcing chemical and pharmaceutical products to supply to various industrial and medical end-users.
Growth Outlook
Growth is expected to be driven by the expanding demand for pharmaceutical intermediates and chemical solvents within the Indian healthcare and veterinary markets.
Key Risks
- Supply Chain Volatility. As a trading company, the firm is susceptible to fluctuations in the availability and pricing of chemical and pharmaceutical raw materials.
- Regulatory Compliance. The business must adhere to stringent pharmaceutical and chemical handling regulations, which may impact operational costs if standards change.
- Market Competition. The trading sector for chemicals and APIs is highly fragmented, leading to intense price competition and pressure on profit margins.
- Foreign Exchange Risk. Fluctuations in currency exchange rates may affect the cost of imported chemicals and the profitability of international trade transactions.
Start your research today
Unlock AI insights, financials, peers and live data on Saroja Pharma In and 5,000+ companies — free.
Peers · Specialty Chemicals
As of Mar 2026